Evaluate the efficacy of an induction regimen with antithymocyte-globulin and basiliximab in patients undergoing kidney transplantation: single center experience
Latest Information Update: 19 Aug 2015
At a glance
- Drugs Antithymocyte globulin (Primary) ; Basiliximab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 19 Aug 2015 New trial record